product image
Rare Cancer Market: A Global Crusade on what is a ‘less common cancer’?

Mar 5, 2021

Cancer is often challenging, however, diagnosis of rare cancer poses extra difficulties. Of all the diagnosed cancers, approximately 22% of the cases are rare cancers. Acco...

Read More
product image
What are the Market Drivers Fueling the Rare Disease Market?

Mar 1, 2021

Rare diseases–also go by the name Orphan diseases–are the conditions that do not affect many individuals out there in one particular geographic area. Going deeper into ...

Read More
product image
Gene and Cell Therapies in CNS Disorders: Miracle Cure? Opportunities Galore!

Feb 26, 2021

CNS disorders are a wide-ranging set of disorders in which the brain loses its normal functioning, limiting everyday ability to function. These may arise from various reaso...

Read More
product image
Clover biopharmaceuticals raises $230 M; BrainStorm after ALS; BARDA grants $5.65 M LightDeck for SARS-CoV-2 antigen test; Libtayo for first-line advanced NSCLC subset

Feb 23, 2021

Clover Biopharmaceuticals Raises $230 Million  Clover Biopharmaceuticals announced the completion of an oversubscribed $230 million Series C financing, summing total c...

Read More
product image
Emerging Research Continues To Transform Erythropoietic Protoporphyria Market Outlook

Feb 22, 2021

Lack of knowledge about conditions, situations, or body ailments that are unexplainable often scares people and leads to people jumping to conclusions or say myths that are...

Read More
product image
Hypofibrinogenemia Market: Limited Pipeline Therapies, Abundant Opportunities

Feb 19, 2021

Like troops at the forefront of any battle, our immune system continually marches to protect us from foreign elements and invaders, including bacteria, viruses, and others....

Read More
product image
Merck, Eisai in renal cancer market; G1 Therapeutics on Cosela’s approval; Takeda’s Maribavir; Astellas/Seagen Padcev

Feb 16, 2021

Merck’s Keytruda-Eisai’s Lenvima Combo Make the Cut in Renal Cancer Numerous immunotherapy-based combinations are already trying in the old game of gleek to sta...

Read More
product image
The Paradox of Rare: Chalking out Challenges in the Rare Disease Market

Feb 15, 2021

How is a Rare disease defined? Well, it depends on the geography in question, since there is no universal definition, even so, the definition revolves around the point of p...

Read More
product image
Limited Therapies in the Pipeline: Watch out for Rare Indications that Calls Out for Novel Therapies

Feb 12, 2021

Rare diseases affect a small percent of the population. In the United States, a rare disease is a condition that affects fewer than 200,000 people in the US (Orphan Drug Ac...

Read More
product image
Deerfield/ Dana-Farber’s USD 130 Million Cancer Research Deal; FDA-Approval to BMS’ Breyanzi & TG Therapeutics’ Ukoniq; EU Marketing Rights for ViiV Healthcare’s Rukobia

Feb 9, 2021

Deerfield and Dana-Farber Establish Links in USD 130 Million Cancer Research Deal  Deerfield Management has entered into a research agreement with Dana-Farber Cancer I...

Read More
product image
Cystic Fibrosis Market: A Rapidly Expanding Playing Field for Mid-Cap Pharma

Feb 8, 2021

Cystic Fibrosis is a rare inherited disorder that causes loss of lung function and damages the digestive system. It has a higher prevalence in the Caucasian population. For...

Read More
product image
The Mesh of the Generics and the Potential of Emerging Therapies in the Smoking Cessation Market

Feb 5, 2021

Smoking is the leading preventable cause of death in the world. However, prior to 1900, tobacco smoking was an uncommon sight. It was not until the 20th century that smokin...

Read More
product image
Chronic Refractory Cough Market and the Monopoly of the Over-The-Counter Drugs

Feb 1, 2021

Cough! Cough! Every time something goes down the wrong pipe, we cough it out. Within seconds, it gets normal. We catch flu, or cold, cough accompanies for a week or two. Ho...

Read More
product image
Notorious Hyperkalemia: What are the causes, signs and new treatments?

Jan 29, 2021

Bananas! Mostly everyone loves bananas. Who wouldn’t? They taste good and they are a rich source of potassium. Besides lovely bananas, oranges, cantaloupe, honeydew, apri...

Read More
product image
A Bleak Pipeline and Lack of Approved Treatment Clouds the Hemophagocytic Lymphohistiocytosis Market Size Growth

Jan 25, 2021

Having a strong immune system, flourished with properly working immune cells is the ultimate key to surviving a healthy life. However, what if a person is in possession of ...

Read More